The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Proton Pump Inhibitors and Risk of Fracture: A Systematic Review and Meta-Analysis of Observational Studies
Abstract
OBJECTIVES: Proton pump inhibitors (PPIs) are widely used in several acid-related gastrointestinal disorders. In vivo studies have suggested that gastric suppression by PPIs could result in decreased intestinal calcium absorption. Subsequently, there have been concerns that the chronic use of a PPI is associated with an increased risk of bone fracture. However, the results of clinical studies are conflicting. METHODS: We performed a systematic review and meta-analysis of controlled observational studies to evaluate the risks of PPI use on fracture outcome. All controlled observational studies that compared fracture outcome in patients with PPI therapy with a control group were included. We calculated pooled odds ratios (ORs) using a random-effects model. RESULTS: Of 1,668 identified studies, 10 (4 cohort and 6 case-control) with 223,210 fracture cases were included in our analysis. In PPI users, compared with non/past users, the OR for hip fracture (n=9) was 1.25 (95% confidence interval (CI)=1.14-1.37). The OR for vertebral fracture (n=4) was 1.50 (95% CI=1.32-1.72) and for wrist/forearm fracture (n=3) was 1.09 (95% CI=0.95-1.24). In subgroup analysis of hip fracture, this association was observed in both high-dose and low-dose PPI exposure. When stratified by duration of exposure, the short duration of PPI use was associated with increased risk of developing hip fracture (OR=1.24; 95% CI=1.19-1.28), whereas there was no significant increase in risk of hip fracture in long-term PPI users (OR=1.30; 95% CI=0.98-1.70). There was significant statistical and clinical heterogeneity among studies for the main analysis and most of the subgroup analyses. CONCLUSIONS: Our results should be interpreted with caution. We found a modest association between PPI use and increased risk of hip and vertebral fractures, but no evidence of duration effect in subgroup analysis. However, observational studies cannot clarify whether the observed epidemiologic association is a causal effect or a result of unmeasured/residual confounding. Thus, randomized controlled studies are required to confirm or refute these results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025
Burge, R., Dawson-Hughes, B., Solomon, D. H., Wong, J. B., King, A., & Tosteson, A. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061113 · Cited by 4,026
The case of the misleading funnel plot
Lau, J., Ioannidis, J. P. A., Terrin, N., Schmid, C. H., & Olkin, I. (2006) · BMJ · doi:10.1136/bmj.333.7568.597 · Cited by 1,766
Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture
Yang, Y.-X., Lewis, J. D., Epstein, S., & Metz, D. C. (2006) · JAMA · doi:10.1001/jama.296.24.2947 · Cited by 1,214
Guidelines for Prevention of NSAID-Related Ulcer Complications
and the Practice Parameters Committee of the American College of Gastroenterology, Lanza, F. L., Chan, F. K. L., & Quigley, E. M. M. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.115 · Cited by 790
Homocysteine Levels and the Risk of Osteoporotic Fracture
van Meurs, J. B. J., Dhonukshe-Rutten, R. A. M., Pluijm, S. M. F., van der Klift, M., de Jonge, R., Lindemans, J., de Groot, L. C. P. G. M., Hofman, A., Witteman, J. C. M., van Leeuwen, J. P. T. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032546 · Cited by 740
Homocysteine as a Predictive Factor for Hip Fracture in Older Persons
McLean, R. R., Jacques, P. F., Selhub, J., Tucker, K. L., Samelson, E. J., Broe, K. E., Hannan, M. T., Cupples, L. A., & Kiel, D. P. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032739 · Cited by 589
Meta-analysis of Observational Studies in Epidemiology
Stroup, D. F., Berlin, J. A., Morton, S. C., Olkin, I., Williamson, G. D., Rennie, D., Moher, D., Becker, B. J., Sipe, T. A., & Thacker, S. B. (2000) · Cited by 473
Use of proton pump inhibitors and risk of osteoporosis-related fractures
Targownik, L. E., Lix, L. M., Metge, C. J., Prior, H. J., Leung, S., & Leslie, W. D. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.071330 · Cited by 436
Gastro-oesophageal reflux disease
Moayyedi, P., & Talley, N. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68932-0 · Cited by 426
O’Connell, M. B., Madden, D. M., Murray, A. M., Heaney, R. P., & Kerzner, L. J. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.02.007 · Cited by 405
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2006) · Calcified Tissue International · doi:10.1007/s00223-006-0021-7 · Cited by 372
Gray, S. L. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.94 · Cited by 329
Corley, D. A., Kubo, A., Zhao, W., & Quesenberry, C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.055 · Cited by 271
Systematic reviews of adverse effects: framework for a structured approach
Loke, Y. K., Price, D., Herxheimer, A., & the Cochrane Adverse Effects Methods Group (2007) · BMC Medical Research Methodology · doi:10.1186/1471-2288-7-32 · Cited by 253
Targownik, L. E., Lix, L. M., Leung, S., & Leslie, W. D. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.11.014 · Cited by 253
Simpson's paradox and calculation of number needed to treat from meta-analysis
Cates, C. J. (2002) · BMC Medical Research Methodology · doi:10.1186/1471-2288-2-1 · Cited by 251
Valuck, R. J., & Ruscin, J. M. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2003.08.015 · Cited by 239
Effect of omeprazole, an inhibitor of H+, K+-ATPase, on bone resorption in humans
Mizunashi, K., Furukawa, Y., Katano, K., & Abe, K. (1993) · Calcified Tissue International · doi:10.1007/bf01352010 · Cited by 238
Acid-Suppressive Medications and Risk of Bone Loss and Fracture in Older Adults
Yu, E. W., Blackwell, T., Ensrud, K. E., Hillier, T. A., Lane, N. E., Orwoll, E., & Bauer, D. C. (2008) · Calcified Tissue International · doi:10.1007/s00223-008-9170-1 · Cited by 210
Lubec, B., Fang-Kircher, S., Lubec, T., Blom, H. J., & Boers, G. H. J. (1996) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(95)00119-0 · Cited by 207
Proton Pump Inhibitor Use and Risk of Hip Fractures in Patients without Major Risk Factors
Kaye, J. A., & Jick, H. (2008) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.8.951 · Cited by 182
Increase in Vertebral Fracture Risk in Postmenopausal Women Using Omeprazole
Roux, C., Briot, K., Gossec, L., Kolta, S., Blenk, T., Felsenberg, D., Reid, D. M., Eastell, R., & Glüer, C. (2008) · Calcified Tissue International · doi:10.1007/s00223-008-9188-4 · Cited by 123
Homocysteine levels and decline in physical function: MacArthur studies of successful aging
Kado, D. M., Bucur, A., Selhub, J., Rowe, J. W., & Seeman, T. E. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01269-x · Cited by 107
Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study
Pouwels, S., Lalmohamed, A., Souverein, P. C., Cooper, C. C., Veldt, B. J., Leufkens, H. G. M., de Boer, A., van Staa, T. P., & de Vries, F. (2010) · Osteoporosis International · doi:10.1007/s00198-010-1337-8 · Cited by 104
de Vries, F., Cooper, A., Cockle, S. M., van Staa, T. P., & Cooper, C. C. (2009) · Osteoporosis International · doi:10.1007/s00198-009-0891-4 · Cited by 102
Kuo, H.-K., Liao, K., Leveille, S. G., Bean, J. F., Yen, C., Chen, J.-H., Yu, Y., & Tai, T. Y. (2007) · The Journals of Gerontology Series A · doi:10.1093/gerona/62.4.434 · Cited by 82
McGowan, B., Bennett, K., & Barry, M. G. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1972 · Cited by 16
Cited by
Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease
Katz, P. O., Gerson, L. B., & Vela, M. F. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.444 · Cited by 1,767
ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease
Katz, P. O., Dunbar, K. B., Schnoll-Sussman, F. H., Greer, K. B., Yadlapati, R., & Spechler, S. J. (2022) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001538 · Cited by 1,038
25 Years of Proton Pump Inhibitors: A Comprehensive Review
Strand, D. S., Kim, D., & Peura, D. A. (2017) · Gut and Liver · doi:10.5009/gnl15502 · Cited by 671
Complications of Proton Pump Inhibitor Therapy
Vaezi, M. F., Yang, Y.-X., & Howden, C. W. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.04.047 · Cited by 482
for the SIF-AIGO-FIMMG Group, Scarpignato, C., on behalf of the Italian Society of Pharmacology, T. I. A. O. H. G., Gatta, L., Zullo, A., & Blandizzi, C. (2016) · BMC Medicine · doi:10.1186/s12916-016-0718-z · Cited by 469
Metadata
- Authors
- Ngamruengphong, S., Leontiadis, G. I., Radhi, S., Dentino, A., & Nugent, K.
- Venue
- American Journal of Gastroenterology
- Published
- 2011-07
- Volume
- 106
- Issue
- 7
- Pages
- 1209-1218
- ISSN
- 0002-9270 (ISSN-L)
- OpenAlex
- W2085777428
- Cited by
- 281
- References
- 29
- FWCI
- 4.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.